Analyst Wants Proof On Arrowhead Research's Hepatitis B Drug
April 14, 2015 at 15:38 PM EDT
Arrowhead Research Corp (NASDAQ: ARWR)'s hepatitis B medicine may prove a cure for the disease, but early data are unimpressive, an ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.